June 10, 2021: Trauma, burden, and COVID-19 risk among PLWH; sleep and viral suppression; spirituality/religioisity, depression, and HIV risk; why anal cancer screening isn't enough.
Fearing discrimination and mistreatment, a significant number of LGBTQ folks are in no rush to get vaccinated, surveys show.
Laws that criminalize not disclosing one’s HIV status increase stigma and discrimination—and ignore scientific evidence.
June 3, 2021: Kaposi sarcoma despite ART; heat-based cervical HPV treatment; re-evaluating HIV-associated neurocognitive disorder; HIV and diabetes in Texas.
A large study finds an increased risk for liver cancer in some HIV-positive people—and offers several interventions that could help reduce the risk.
May 27, 2021: Recycling tenofovir in a second-line regimen; real-life two-drug regimen failure rates; jump-starting ART at sexual health clinics; viability of wearable devices in sleep assessment.
Four months after the approval of cabotegravir/rilpivirine, medical providers still face some tough questions about who might best benefit and how the medication might be covered.
May 20, 2021: HIV testing and prevalence trends in the U.S.; groups at higher risk for losing viral suppression; intent vs. reality in making clinic appointments; transitioning from pediatric to adult HIV care.
New York physicians, physician assistants, and nurses may soon be required to talk about sex, gender identity, STIs, and HIV.
A recent study finds viral suppression rates and CD4+ cell counts were significantly lower among people experiencing homelessness.